医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Grand Opening Phyathai Nawamin International Hospital in Bangkok Thailand

2014年12月20日 PM09:26
このエントリーをはてなブックマークに追加


 

BANGKOK

Phyathai Hospital group opened Phyathai Nawamin International Hospital, the latest branch that aims to be the leading Healthcare provider for both local and overseas clients.

Phyathai Nawamin International Hospital, formerly known as Paolo Nawamin Memorial Hospital, has been renovated by the Phyathai Hospital Group to be the leader of international standard hospitals in Bangkok Thailand.

Phyathai Hospital is a group of 8 hospitals, with an established name as a leading healthcare provider to both local and international clients. Phyathai Nawamin International Hospital was then established in 1995 as the 5th hospital of Phyathai group due to the large demand for excellent medical-surgical treatment.

Phyathai Nawamin International Hospital, formerly known as Paolo Nawamin Memorial hospital, a 250 bed facility with international standard, is located at 44/505 Nawamin Road Nuanchan, Bunggoom, Bangkok Thailand. The main goal is to provide excellent service and to become the world class treatment and quality care under ISO 9001, 14001, 18001 and HACCP standards. Phyathai Hospitals have got the Hospital Accreditation Projects accredited by the Ministry of Public Health since 1997.

Phyathai Nawamin International Hospital offers medical services with state-of the-art-facilities and is fully-equipped with modern advanced technology and equipment. All high-experienced physicians and well-trained staffs are keen to treat you well as an important person.

If have any further question about Phyathai Nawamin International Hospital, please feel free to contact us.

Please Visit: Phyathai Nawamin International Hospital

CONTACT

Phyathai
Nawamin International Hospital

Ms.Sinsaruta Klinsukhon,
66859742455
International Correspondence Center

同じカテゴリーの記事 

  • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market
  • BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
  • Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
  • joimax® Obtains Registration for All Products in the Indian Market
  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China